Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites
NCT03230708
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Malignant Ascites
Interventions
OTHER:
Erythrocytes derived MPs containing MTX
DRUG:
convention drugs
Sponsor
Hui ting Xu，MD